| Literature DB >> 30713007 |
Eóin C O'Brien1, Rachel M McLoughlin2.
Abstract
Staphylococcus aureus is an opportunistic pathogen, which can readily develop antibiotic resistance and result in severe disease. To combat antibiotic resistance, new treatment strategies are being developed with a particular focus on vaccine development. S. aureus vaccines that target humoral immunity alone do not provide sufficient protection from all disease phenotypes associated with this pathogen. Recent studies have identified the requirement for cellular immunity to provide a robust immune response to this infection. Driving conventional T cell responses has therefore become the focus of intense research in this area. Recently described 'alternative' T cells could provide a novel strategy for improving therapeutic efficacy and success in next-generation anti-S. aureus vaccine design.Entities:
Keywords: MAIT cells; Staphylococcus aureus; innate lymphoid cells; γδ cells
Mesh：
Substances：
Year: 2019 PMID： 30713007 DOI： 10.1016/j.molmed.2018.12.010
Source DB: PubMed Journal: Trends Mol Med ISSN： 1471-4914 Impact factor: 11.951